M Javad Aman Selected Research

Filoviridae Infections

1/2018	Design and evaluation of bi- and trispecific antibodies targeting multiple filovirus glycoproteins.
12/2010	Identification of essential filovirion-associated host factors by serial proteomic analysis and RNAi screen.
5/2010	Antiviral activity of a small-molecule inhibitor of filovirus infection.
4/2007	NKp30-dependent cytolysis of filovirus-infected human dendritic cells.
9/2004	Marburg virus-like particles protect guinea pigs from lethal Marburg virus infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

M Javad Aman Research Topics

Disease

29	Infections 06/2022 - 03/2002
8	Ebola Hemorrhagic Fever 12/2021 - 07/2004
5	Septic Shock (Toxic Shock Syndrome) 10/2019 - 07/2012
5	Filoviridae Infections 01/2018 - 09/2004
4	Virus Diseases (Viral Diseases) 01/2021 - 04/2005
3	COVID-19 01/2022 - 01/2021
3	Pneumonia (Pneumonitis) 01/2022 - 01/2012
3	Fever (Fevers) 12/2014 - 04/2005
3	Sepsis (Septicemia) 01/2013 - 01/2012
2	Viremia 12/2021 - 05/2010
2	Vesicular Stomatitis 02/2021 - 05/2010
2	Weight Loss (Weight Reduction) 01/2021 - 12/2016
2	American Hemorrhagic Fever (Bolivian Hemorrhagic Fever) 01/2021 - 04/2016
2	Foodborne Diseases 10/2019 - 01/2019
2	Bacteremia 09/2012 - 01/2012
1	Musculoskeletal Diseases (Musculoskeletal Disease) 01/2021
1	Alphavirus Infections 01/2021
1	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 12/2020
1	Staphylococcal Pneumonia 01/2020
1	Microcephaly 01/2020
1	Zika Virus Infection 01/2020
1	Necrotizing Pneumonia 01/2020
1	Primate Diseases 01/2019
1	Body Weight (Weight, Body) 01/2019
1	Infectious Arthritis (Septic Arthritis) 01/2019
1	Soft Tissue Infections 12/2016
1	Necrosis 12/2016
1	Wound Infection (Wound Infections) 12/2016
1	Chronic Hepatitis C 12/2016
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2012
1	Viral Hemorrhagic Fevers (Viral Hemorrhagic Fever) 09/2011
1	HIV Infections (HIV Infection) 05/2010
1	Anthrax 08/2005
1	Marburg Virus Disease 01/2004
1	Shock 08/2002

Drug/Important Bio-Agent (IBA)

20	VaccinesIBA 01/2022 - 08/2002
11	Glycoproteins (Glycoprotein)IBA 06/2022 - 07/2004
9	Proteins (Proteins, Gene)FDA Link 01/2022 - 07/2004
8	Monoclonal AntibodiesIBA 01/2022 - 07/2012
5	Hemolysin Proteins (Hemolysins)IBA 01/2020 - 01/2012
4	EpitopesIBA 01/2022 - 01/2016
4	CytokinesIBA 04/2017 - 08/2002
3	Virulence Factors (Pathogenicity Factors)IBA 01/2022 - 09/2012
3	ToxoidsIBA 01/2021 - 01/2019
3	AntibodiesIBA 01/2021 - 01/2013
3	Panton-Valentine leukocidinIBA 01/2020 - 09/2012
3	Immunoglobulin G (IgG)IBA 10/2019 - 09/2012
3	SuperantigensIBA 01/2019 - 03/2016
3	Enterotoxins (Enterotoxin)IBA 12/2016 - 09/2012
2	Neutralizing AntibodiesIBA 02/2021 - 05/2017
2	Broadly Neutralizing AntibodiesIBA 01/2021 - 12/2016
2	Biological Warfare AgentsIBA 10/2019 - 08/2005
2	staphylococcal enterotoxin BIBA 10/2019 - 07/2012
2	NucleoproteinsIBA 01/2019 - 01/2015
2	Antiviral Agents (Antivirals)IBA 12/2016 - 05/2010
2	Small Interfering RNA (siRNA)IBA 12/2010 - 05/2010
2	MorpholinosIBA 11/2007 - 01/2006
1	Biomarkers (Surrogate Marker)IBA 06/2022
1	Biological ProductsIBA 01/2022
1	Viral RNAIBA 12/2021
1	sphingosine kinaseIBA 04/2021
1	SolutionsIBA 01/2021
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2020
1	Messenger RNA (mRNA)IBA 01/2020
1	Beclin-1IBA 01/2020
1	Insulin-Like PeptidesIBA 01/2020
1	AerosolsIBA 01/2019
1	Staphylococcal enterotoxin FIBA 01/2019
1	Polysaccharides (Glycans)IBA 01/2019
1	Investigational DrugsIBA 01/2019
1	Ebola VaccinesIBA 05/2017
1	Subunit VaccinesIBA 12/2016
1	Complement System Proteins (Complement)IBA 12/2016
1	AntigensIBA 03/2016
1	Surface Antigens (Surface Antigen)IBA 03/2014
1	Immunoglobulins (Immunoglobulin)IBA 01/2013
1	staphylococcal delta toxinIBA 09/2012
1	ExotoxinsIBA 09/2012
1	EmulsionsIBA 01/2012
1	LipidsIBA 01/2012
1	Interleukin-12 (IL 12)IBA 01/2012
1	RestonIBA 09/2011
1	Peptides (Polypeptides)IBA 09/2011
1	ClathrinIBA 05/2010
1	Clathrin Heavy ChainsIBA 05/2010
1	Sucrose (Saccharose)IBA 05/2010
1	Chlorpromazine (Thorazine)FDA Link 05/2010
1	FGI 103IBA 05/2010
1	Antisense OligonucleotidesIBA 11/2007
1	PerforinIBA 04/2007
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 08/2002
1	HLA Antigens (Human Leukocyte Antigens)IBA 08/2002
1	Streptococcus pyogenes SpeA proteinIBA 08/2002
1	CD4 Antigens (CD4 Antigen)IBA 08/2002
1	Alanine (L-Alanine)FDA Link 08/2002
1	Interleukin-4 (Interleukin 4)IBA 02/2002

Therapy/Procedure

8	Therapeutics 01/2021 - 03/2002
1	Artificial Respiration (Mechanical Ventilation) 01/2022
1	Critical Care (Surgical Intensive Care) 01/2022
1	Aftercare (After-Treatment) 12/2021